Please provide your email address to receive an email when new articles are posted on . The introduction of long-acting injectable cabotegravir PrEP in sub-Saharan Africa could result in fewer future ...
Introduction Towards the ‘End TB Strategy’ targets, the WHO recommends the provision of tuberculosis (TB) preventive therapy (TPT) for high-risk groups including people living with HIV (PLWH). 3 years ...
A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability that could lead to new therapies and bring the world closer to a ...
Many HIV-serodiscordant couples desire children and physician-assisted techniques can help individuals achieve pregnancy while reducing the risk of seroconversion in their seronegative partner. For ...
Introduction Maximising the impact of new and forthcoming long-acting injectable HIV pre-exposure prophylaxis (PrEP) products ...
Share on Pinterest From newly approved medications to promising research on the road to a potential cure, 2022 was a year filled with significant advancements in HIV care and prevention. Natalie ...
A person with HIV may be more at risk of developing tuberculosis (TB). This is due to the weakening of the immune system that occurs in someone who has HIV. Tuberculosis (TB) is a bacterial infection ...
An in-depth look at HIV epidemiology in Mizoram, examining rising infection rates, drug use, trafficking, and public health responses.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results